Publication

Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.

Journal Paper/Review - Apr 30, 2019

Units
PubMed
Doi
Contact

Citation
Seiffge D, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M, Schaedelin S, Shakeshaft C, Takagi M, Tsivgoulis G, Bonetti B, Kallmünzer B, Arihiro S, Alberti A, Polymeris A, Ambler G, Yoshimura S, Venti M, Bonati L, Muir K, Yamagami H, Thilemann S, Altavilla R, Peters N, Inoue M, Bobinger T, Agnelli G, Brown M, Sato S, Acciarresi M, Jäger H, Bovi P, Schwab S, Lyrer P, Caso V, Toyoda K, Werring D, Engelter S, De Marchis G, CROMIS-2, RAF, RAF-DOAC, SAMURAI, NOACISP LONGTERM, Erlangen and Verona registry collaborators. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann Neurol 2019; 85:823-834.
Type
Journal Paper/Review (English)
Journal
Ann Neurol 2019; 85
Publication Date
Apr 30, 2019
Issn Electronic
1531-8249
Pages
823-834
Brief description/objective

We compared outcomes after treatment with direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) and a recent cerebral ischemia.